"Zosurabalpin: A New Antibiotic Breakthrough Battles Drug-Resistant Superbugs"

Swiss scientists have discovered a new antibiotic, zosurabalpin, which is effective against drug-resistant gram-negative bacteria, specifically targeting Acinetobacter baumannii. This breakthrough, the first in over 50 years, could combat the growing issue of antimicrobial resistance, which is responsible for millions of deaths annually. Zosurabalpin operates by blocking the bacteria's ability to form a protective outer membrane, leading to its death. Currently in phase 1 clinical trials, this discovery opens the door to potentially treating a range of drug-resistant infections and is a significant step forward in the fight against the "silent pandemic" of antibiotic resistance.